Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs dexmedetomidine for sleep quality and cognition in ICU patients
ChiCTR2300078499Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and dexmedetomidine in sleep disorder, delirium and confusion (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Proportion of sleep stages and Sleep quality. Started Dec 2023; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
sleep disorderdeliriumconfusion
Beyond the preview
Go deeper on ChiCTR2300078499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078499.